Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NXTVSION is a Malaysia-based healthcare and nutraceutical company specializing in evidence-based wellness solutions, most notably its flagship joint health brand, Oriactiv Flexy3. The company's primary product, Flexy3, utilizes a clinically validated "3-in-1" formula combining Boswellia serrata, Turmeric extract, and plant-based MSM to address joint inflammation and support cartilage repair. NXTVSION distinguishes itself in the supplement market through a commitment to clinical integrity, having conducted randomized, placebo-controlled human trials to demonstrate the efficacy of its formulations. The company primarily serves the Southeast Asian market, with a strong presence in the Malaysian joint care sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Flexy3.